ATE117545T1 - Arzneimittel mit verbesserter auflösungsgeschwindigkeit. - Google Patents

Arzneimittel mit verbesserter auflösungsgeschwindigkeit.

Info

Publication number
ATE117545T1
ATE117545T1 AT90122693T AT90122693T ATE117545T1 AT E117545 T1 ATE117545 T1 AT E117545T1 AT 90122693 T AT90122693 T AT 90122693T AT 90122693 T AT90122693 T AT 90122693T AT E117545 T1 ATE117545 T1 AT E117545T1
Authority
AT
Austria
Prior art keywords
improved dissolution
medicinal products
dissolution speed
pharmaceutical compositions
preparations
Prior art date
Application number
AT90122693T
Other languages
English (en)
Inventor
Kenji Ogawa
Toshiyuki Shibata
Hirofumi Samemoto
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of ATE117545T1 publication Critical patent/ATE117545T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90122693T 1989-05-30 1990-11-28 Arzneimittel mit verbesserter auflösungsgeschwindigkeit. ATE117545T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1138340A JPH0818985B2 (ja) 1989-05-30 1989-05-30 溶出性の改良された製剤組成物

Publications (1)

Publication Number Publication Date
ATE117545T1 true ATE117545T1 (de) 1995-02-15

Family

ID=15219630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90122693T ATE117545T1 (de) 1989-05-30 1990-11-28 Arzneimittel mit verbesserter auflösungsgeschwindigkeit.

Country Status (5)

Country Link
EP (1) EP0487768B1 (de)
JP (1) JPH0818985B2 (de)
AT (1) ATE117545T1 (de)
DE (1) DE69016439T2 (de)
ES (1) ES2067634T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05255125A (ja) * 1992-02-29 1993-10-05 Upjohn Co:The 徐放性製剤およびその製法
PT1200090E (pt) * 1999-08-03 2013-11-25 Icos Corp Formulação farmacêutica à base de um beta-carbolina e seu uso para tratar a disfunção sexual.
MX2008011418A (es) * 2006-03-06 2008-09-22 Teva Pharma Composiciones de ezetimibe.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3867086D1 (de) * 1987-03-02 1992-02-06 Yoshitomi Pharmaceutical Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.

Also Published As

Publication number Publication date
JPH0818985B2 (ja) 1996-02-28
DE69016439D1 (de) 1995-03-09
EP0487768B1 (de) 1995-01-25
DE69016439T2 (de) 1995-06-29
ES2067634T3 (es) 1995-04-01
EP0487768A1 (de) 1992-06-03
JPH032120A (ja) 1991-01-08

Similar Documents

Publication Publication Date Title
AU617918B2 (en) 2-aminopyrimidinone derivatives
NO905572L (no) Fremgangsmaate for fremstilling av peptidforbindelser.
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
NL930077I2 (nl) Gesubstitueerde acylderivaten van 1,2,3,4-tetrahydroisochinoline-3-carbozuren, zouten ervan, farmaceutische preparaten die de derivaten of zouten bevatten en de bereiding daarvan.
DE3586794D1 (de) Arzneimittel mit psychotroper wirkung.
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
IL101544A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
FI944823A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
CA2119662A1 (fr) Nouveaux derives bicycliques azotes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IE960774L (en) Arylalkylamides having neuroprotective properties
KR900003177A (ko) 테트라시클릭계 우울증 치료제
ATE117545T1 (de) Arzneimittel mit verbesserter auflösungsgeschwindigkeit.
ATE161837T1 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
HU900255D0 (en) Process for preparation of 3-phenyl-5,6-dilhydrobenz (c)-acridine-carboxylic-acids and carboxylic-acid derivatives and for manufacturing of pharmaceutical composition containing these compounds as active ingredient
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
KR930023338A (ko) 데포우 제제
JPS57200361A (en) "indomethacin(r)" pharmaceutical with low irritant action
IE893258L (en) New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
AU1214292A (en) Indane derivatives
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee